Connecting Audio and Radio Sensing Systems to Improve Care at Home (NCT05344950) | Clinical Trial Compass
CompletedNot Applicable
Connecting Audio and Radio Sensing Systems to Improve Care at Home
United States13 participantsStarted 2022-03-21
Plain-language summary
This study aims to assess the usability of the innovative Audio + Radio (AURA) system in enhancing personalized supportive care for cancer patients and caregivers during the post-ostomy care transition by collecting information on patient's daily activities and answers to survey questionnaire, and enabling access to this information through a voice assistant device.
Who can participate
Age range18 Years – 99 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria
Phase I: The investigators will only be recruiting patients for this phase
Patients must:
* have been surgically treated for colorectal or bladder cancer with curative intent;
* have had an ostomy with curative intent for at least 90 days;
* be able to read and speak English;
* be 18 years or older;
Phase II: The investigators will be recruiting patients and caregivers as a dyad for this phase
* Patients must:
* have been surgically treated for colorectal or bladder cancer with curative intent;
* be within one month of hospital discharge of a newly created ostomy with curative intent;
* be able to read and speak English;
* be 18 years or older;
* have a caregiver who is willing to participate in the study;
* Caregivers must:
* be 18 years or older;
* be able to read and speak English;
* be identified as the primary caregiver by the patient;
* have not themselves been diagnosed with cancer or received cancer treatment during the study (to ensure that patients and caregivers focus their efforts on care of the patient).
Exclusion Criteria
Patients and their caregivers will be excluded if they:
* are unable to read, speak, or understand English;
* have more than one type of ostomy;
* have other cancer diagnosis (excluding non-melanomatous skin cancer); or
* have cognitive impairment (assessed by the Short Portable Mental Status Questionnaire).